Altium Capital Management LLC

Investment Portfolio & 13F Holdings Analysis

About
CIK: 0001746382
Type: FundHoldings: 23Value: $41.2MLatest: 2025Q1

Altium Capital Management LLC is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 23 holdings worth $0.0 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

Filing Details

13F-HR/A2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-13
Total Holdings
23
Total Value
41184642
Accession Number
0001420506-25-000988
Form Type
13F-HR/A
Manager Name
Altium-Capital-Management
Data Enrichment
78% identified
18 identified5 unidentified

Holdings

23 positions
Manager:
Search and click to pin securities to the top
Page 1 of 2
488445206
Shares:1.3M
Value:$9.6M
ALNYLAM PHARMACEUTICALS, INC.
Shares:25.0K
Value:$6.8M
Evolus, Inc.
Shares:296.2K
Value:$3.6M
Xtant Medical Holdings, Inc.
Shares:7.3M
Value:$3.4M
AVADEL PHARMACEUTICALS PLC
Shares:419.1K
Value:$3.3M
Contineum Therapeutics, Inc.
Shares:303.9K
Value:$2.1M
Profound Medical Corp.
Shares:360.6K
Value:$2.1M
Xenon Pharmaceuticals Inc.
Shares:60.3K
Value:$2.0M
ESSA Pharma Inc.
Shares:1.1M
Value:$1.7M
Skye Bioscience, Inc.
Shares:904.9K
Value:$1.4M
Alpha Cognition Inc.
Shares:177.4K
Value:$897.7K
Rezolute, Inc.
Shares:303.9K
Value:$881.5K
NEKTAR THERAPEUTICS
Shares:1.1M
Value:$714.9K
Anteris Technologies Global Corp.
Shares:168.6K
Value:$613.7K
Larimar Therapeutics, Inc.
Shares:273.2K
Value:$587.4K
ProMIS Neurosciences Inc.
Shares:574.2K
Value:$399.4K
enVVeno Medical Corp
Shares:123.3K
Value:$324.2K
INTELLIGENT BIO SOLUTIONS INC.
Shares:149.3K
Value:$214.9K
Karyopharm Therapeutics Inc.
Shares:49.3K
Value:$184.5K
82003F200
Shares:4.0M
Value:$110.4K